{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-020349","form_type":"8-K","ticker":"BTAI","cik":"0001720893","company_name":"BioXcel Therapeutics, Inc.","filed_at":"2025-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.584560+00:00","generated_at":"2026-05-25T14:36:57.769860+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"BioXcel Therapeutics raises $14M in registered direct offering with warrants","bullets":["Total gross proceeds of $14M from sale of 188,383 shares and pre-funded warrants for up to 3,811,617 shares.","Combined offering price: $3.50 per share + accompanying warrant; $3.499 per pre-funded warrant + accompanying warrant.","Warrants exercisable at $4.20 per share; option warrants to purchase up to 4,000,000 additional shares.","Placement agent Rodman & Renshaw receives a 6.0% cash fee on gross proceeds.","Closing expected on first Trading Day after March 3, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-020349","json":"https://secwatch.observer/filing/0001104659-25-020349.json","markdown":"https://secwatch.observer/filing/0001104659-25-020349.md","text":"https://secwatch.observer/filing/0001104659-25-020349.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1720893/000110465925020349/0001104659-25-020349-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1720893/000110465925020349/tm258193-1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T14:36:57.769860+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}